Open Access

[Corrigendum] 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5

  • Authors:
    • Yuzhong Chen
    • Li Wei
    • Xiaojing Zhang
    • Xianfu Liu
    • Yansong Chen
    • Song Zhang
    • Lanzhu Zhou
    • Qixiang Li
    • Qiong Pan
    • Surong Zhao
    • Hao Liu
  • View Affiliations

  • Published online on: January 17, 2022     https://doi.org/10.3892/or.2022.8264
  • Article Number: 53
  • Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Rep 40: [Related article:] 2435-2444, 2018; DOI: 10.3892/or.2018.6644

Following the publication of this article, an interested reader drew to the authors attention that the western blotting data shown in Fig. 3 on. p. 2439 contained apparent anomalies; first, the protein bands shown to represent the CHOP and p-AMPK experiments in Fig. 3A were strikingly similar. Secondly, the same data bands were inadvertently included in the figure to represent the GRP78 and Bax experiments for the MCF-7 group. The authors have re-examined their original data and realized that this figure was assembled incorrectly (the CHOP and GRP78 data were inadvertently duplicated in the figure).

The corrected version of Fig. 3, showing the correct data for the p-AMPK and Bax experiments for the MCF-7 group in Fig. 3A, is shown on the next page. The authors sincerely apologize for the error that was introduced during the preparation of this figure, thank the Editor of Oncology Reports for granting them the opportunity to publish a Corrigendum, and are grateful to the reader for alerting them to this issue. The authors also regret any inconvenience that this mistake may have caused.

Related Articles

Journal Cover

March-2022
Volume 47 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen Y, Wei L, Zhang X, Liu X, Chen Y, Zhang S, Zhou L, Li Q, Pan Q, Zhao S, Zhao S, et al: [Corrigendum] 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5. Oncol Rep 47: 53, 2022
APA
Chen, Y., Wei, L., Zhang, X., Liu, X., Chen, Y., Zhang, S. ... Liu, H. (2022). [Corrigendum] 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5. Oncology Reports, 47, 53. https://doi.org/10.3892/or.2022.8264
MLA
Chen, Y., Wei, L., Zhang, X., Liu, X., Chen, Y., Zhang, S., Zhou, L., Li, Q., Pan, Q., Zhao, S., Liu, H."[Corrigendum] 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5". Oncology Reports 47.3 (2022): 53.
Chicago
Chen, Y., Wei, L., Zhang, X., Liu, X., Chen, Y., Zhang, S., Zhou, L., Li, Q., Pan, Q., Zhao, S., Liu, H."[Corrigendum] 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5". Oncology Reports 47, no. 3 (2022): 53. https://doi.org/10.3892/or.2022.8264